Crinetics Pharmaceuticals, Inc. (CRNX)
47.86
+0.46
(+0.96%)
USD |
NASDAQ |
Dec 09, 16:00
47.86
0.00 (0.00%)
After-Hours: 16:37
Crinetics Pharmaceuticals Shareholders Equity (Quarterly): 1.072B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 23.79B |
| Amgen, Inc. | 9.619B |
| Madrigal Pharmaceuticals, Inc. | 625.73M |
| United Therapeutics Corp. | 6.590B |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.196B |
| Total Liabilities (Quarterly) | 123.86M |
| Debt to Equity Ratio | 0.0458 |
| Current Ratio | 15.12 |
| Net Debt Paydown Yield | 0.02% |